Skip to main content

Table 2 Post-ablation imaging, biochemical and pathological data

From: Anterior gland focal cryoablation: proof-of-concept primary prostate cancer treatment in select men with localized anterior cancers detected by multi-parametric magnetic resonance imaging

Follow-up (mos.), median (IQR)15 (13,17)
PSA nadir (ng/ml), median (IQR)0.82 (0.55, 1.75)
Time to nadir (mos.), median (IQR)4 (3, 7.5)
Time to MRI (mos.), median (IQR)14 (13, 15)
No. positive biopsy (%):
 PGG 12 (100)
  1. PGG prognostic grade group